In its injectables business, Hikma said a good mix of products will generate operating profit margins of 39%, up from the 38% previously anticipated. Respiratory drugs have in the past proved ...

“Hikma was part of an industry that flooded the country with dangerous opioids, profiting off the products that have caused our current national public health crisis,” commented New York ...

Analyst Christian Glennie from Stifel Nicolaus reiterated a Buy rating on Hikma Pharmaceuticals (HIK – Research Report) and keeping the ...

The acquisition will add eight approved and marketed injectable products to Hikma's US portfolio, and 11 pipeline products.

Hikma Pharmaceuticals Usa Inc was founded in 2011 and operates in Eatontown, United States. The company engages in the sector 'Pharmaceuticals, Medicinal Chemical & Botanical Products' (ISIC ...

In a remarkable recognition of Assam’s cultural diversity and traditional knowledge, the Geographical Indications (GI) ...

Hikma Pharmaceuticals (GB:HIK) has released an update. Hikma Pharmaceuticals has decided to reappoint PricewaterhouseCoopers LLP as its external auditor starting in 2026, following a competitive ...

Shares of Hikma Pharmaceuticals PLC HIK inched down 0.99% to £19.98 Friday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE 100 Index UKX falling 0. ...

Shares of Hikma Pharmaceuticals PLC HIK inched down 0.60% to £18.26 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the FTSE 100 Index UKX falling 1.22% to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.